Over the next few years, cancer will become number one cause of death in our country. At present, nearly 157,000 Poles are diagnosed with malignant tumours every year and approximately 95,000 of them die. But contemporary medicine makes it possible to detect genes which may increase the risk of cancer development. Genetic predisposition tests are available, for instance, in the Medicover Medical Centre at Aleje Jerozolimskie 96.
Who should take a test for genetic susceptibility to cancer?
The test covers more than 60 different genes. In the course of the patient’s DNA analysis, gene mutations are detected which increase the person’s risk of developing cancer.
The presence of a gene mutation does not mean that the patient will certainly have cancer, but as the probability of developing the disease is higher, appropriate steps should be taken to mitigate the risk. In the case of prostate cancer, the second most frequently diagnosed tumour in men, the risk of developing the disease in a person with genetic predispositions is nearly 40 percent higher, while in the case of breast cancer in women the risk grows by as much as 84 percent. That is why it is really worthwhile to take advantage of the advances in modern medicine and minimise the risk of developing the disease ahead of the time.
Agnieszka Motyl, MD, Medical Quality Manager at Medicover
What does the genetic screening procedure in Medicover Centre look like?
During the first visit to the centre, a blood sample is taken from the patient. The genetic test is carried out using a state-of-the-art DNA analysis method (so called New Generation Sequencing – NGS). On the basis of the test results and the information provided in the questionnaire, a specialist in genetic diagnostics issues an opinion with individual recommendations for a patient which is sent to the Medicover Centre. In order to make sure that the test has a desirable effect and increases the patient’s awareness , a second visit to the Centre is arranged, during which a specialist physician discusses the results with the patient and agrees on an individual prevention plan covering both mitigation of the disease risk and early detection.